The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(8-methoxy-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl)ethan-1-one ID: ALA3110262
Cas Number: 1040695-96-2
PubChem CID: 29147548
Max Phase: Preclinical
Molecular Formula: C14H16N2O2
Molecular Weight: 244.29
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2[nH]c3c(c2c1)CN(C(C)=O)CC3
Standard InChI: InChI=1S/C14H16N2O2/c1-9(17)16-6-5-14-12(8-16)11-7-10(18-2)3-4-13(11)15-14/h3-4,7,15H,5-6,8H2,1-2H3
Standard InChI Key: CTOQTKICLRDBJE-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
16.7435 -28.6897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9747 -29.4760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7696 -29.6676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3039 -28.0978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0983 -28.2857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3362 -29.0737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7743 -27.8160 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4300 -28.3136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1619 -29.0915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6985 -29.7093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5061 -29.5549 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7742 -28.7770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2348 -28.1535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0411 -30.1725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7737 -30.9447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8436 -30.0180 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4113 -30.0679 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6169 -29.8760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 9 1 0
8 7 1 0
7 5 1 0
8 9 2 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
11 14 1 0
14 15 1 0
14 16 2 0
2 17 1 0
17 18 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 244.29Molecular Weight (Monoisotopic): 244.1212AlogP: 2.08#Rotatable Bonds: 1Polar Surface Area: 45.33Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 0.81CX LogD: 0.81Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.83Np Likeness Score: -1.05
References 1. Ferguson FM, Fedorov O, Chaikuad A, Philpott M, Muniz JR, Felletar I, von Delft F, Heightman T, Knapp S, Abell C, Ciulli A.. (2013) Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain., 56 (24): [PMID:24304323 ] [10.1021/jm401582c ] 2. Rice AJ, Lei H, Santarsiero BD, Lee H, Johnson ME.. (2016) Ca-asp bound X-ray structure and inhibition of Bacillus anthracis dihydroorotase (DHOase)., 24 (19): [PMID:27499369 ] [10.1016/j.bmc.2016.07.055 ]